ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution

RTTNews | 717 days ago
Stocktwits
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.

Methsuximide Capsules has been granted 180-day Competitive Generic Therapy (CGT) Exclusivity, and Alendronate Sodium Oral Solution is eligible for CGT Exclusivity upon launch.

ANI's Methsuximide Capsules are the generic version of the Reference Listed Drug (RLD) Celontin Capsules and ANI's Alendronate Sodium Oral Solution is the generic version of the RLD Fosamax Oral Solution.

The current annual U.S. market for Methsuximide Capsules and Alendronate Sodium Oral Solution is approximately $6.3 million, according to IQVIA, a leading healthcare data and analytics provider.

Tags: ANIP ANIP,
Stocktwits
read more
UK Market Ends Slightly Up

UK Market Ends Slightly Up

On a day in which most of the markets across Europe remained closed for Labor Day holiday, the UK market, where trading was on, ended marginally up on Thursday, extending its gains to a 13th straight session.
RTTNews | 1h 41min ago
Canadian Market Retreats After Recovering From Early Drop

Canadian Market Retreats After Recovering From Early Drop

The Canadian market is modestly higher around noon on Thursday with shares from energy and technology sectors posting strong gains. A sell-off in materials section is limiting market's upside. The mood in the market is quite cautious amid concerns about global economic growth.
RTTNews | 2h 22min ago
U.S. Construction Spending Unexpectedly Falls 0.5% In March

U.S. Construction Spending Unexpectedly Falls 0.5% In March

Construction spending in the U.S. unexpectedly decreased in the month of March, the Commerce Department revealed in a report released on Thursday. The Commerce Department said construction spending fell by 0.5 percent to an annual rate of $2.196 trillion in March after climbing by 0.6 percent to a revised rate of $2.207 trillion in February.
RTTNews | 4h 6min ago
U.S. Manufacturing Index Dips Slightly Further Into Contraction Territory In April

U.S. Manufacturing Index Dips Slightly Further Into Contraction Territory In April

The Institute for Supply Management released a report on Thursday showing a slight decrease by its reading on U.S. manufacturing activity in the month of April. The ISM said its manufacturing PMI edged down to 48.7 in April after slipping to 49.0 in March, with a reading below 50 indicating contraction. Economists had expected the index to dip to 48.0.
RTTNews | 4h 19min ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviews
Brokers
Prop Trading Firms
VPS Services
Signal Providers
EA Programming Services
Affiliate Programs
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Crypto Exchanges
Trading Courses
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Press Release
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.